Product Program year 2025 Source: CMS Open Payments

Coagadex

Drug Coagulation Factor X Human

NDC 64208-7752-1

Open in the dashboard

General payments

$19,007

13 payments

Research payments

$0

0 payments

Through program year 2025, $19,007 in general payments and $0 in research payments were reported against Coagadex (Coagulation Factor X Human).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $19,007 13

Breakdown

Who paid General payments · program year 2025
  1. Kedrion Biopharma, Inc. $19,007 13 payments
Top recipients General payments · program year 2025
  1. Tammuella Chrisentery-Singleton Pediatric Hematology-Oncology · New Orleans, LA $14,677 77% · 5 payments
  2. Michael Tarantino Pediatric Hematology-Oncology · Peoria, IL $1,800 9% · 1 payment
  3. Meera Chitlur Pediatrics · Detroit, MI $1,800 9% · 1 payment
  4. Luis Omphroy Ophthalmology · Aiea, HI $125 <1% · 1 payment
  5. Nancy Chen Ophthalmology · Kapolei, HI $125 <1% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $16,477 87% · 2 practitioners
  2. Pediatrics $1,800 9% · 1 practitioner
  3. Ophthalmology $375 2% · 3 practitioners
  4. Optometrist $250 1% · 2 practitioners
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $105 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Louisiana $14,677 77% · 1 recipient
  2. Illinois $1,800 9% · 1 recipient
  3. Michigan $1,800 9% · 1 recipient
  4. Hawaii $500 3% · 4 recipients
  5. Arizona $125 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

13 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record